NM_001540.5:c.80G>C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 4P and 9B. PM1PP3_ModerateBP6BS1BS2

The NM_001540.5(HSPB1):​c.80G>C​(p.Arg27Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000302 in 1,608,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R27H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00032 ( 0 hom. )

Consequence

HSPB1
NM_001540.5 missense

Scores

11
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:3

Conservation

PhyloP100: 9.10

Publications

5 publications found
Variant links:
Genes affected
HSPB1 (HGNC:5246): (heat shock protein family B (small) member 1) This gene encodes a member of the small heat shock protein (HSP20) family of proteins. In response to environmental stress, the encoded protein translocates from the cytoplasm to the nucleus and functions as a molecular chaperone that promotes the correct folding of other proteins. This protein plays an important role in the differentiation of a wide variety of cell types. Expression of this gene is correlated with poor clinical outcome in multiple human cancers, and the encoded protein may promote cancer cell proliferation and metastasis, while protecting cancer cells from apoptosis. Mutations in this gene have been identified in human patients with Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. [provided by RefSeq, Aug 2017]
HSPB1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease axonal type 2F
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
  • neuronopathy, distal hereditary motor, type 2B
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • distal hereditary motor neuropathy type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

PM1
In a chain Heat shock protein beta-1 (size 204) in uniprot entity HSPB1_HUMAN there are 29 pathogenic changes around while only 8 benign (78%) in NM_001540.5
PP3
MetaRNN computational evidence supports a deleterious effect, 0.913
BP6
Variant 7-76302792-G-C is Benign according to our data. Variant chr7-76302792-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 245625.
BS1
Variant frequency is greater than expected in population sas. GnomAdExome4 allele frequency = 0.000316 (460/1456266) while in subpopulation SAS AF = 0.000372 (32/86090). AF 95% confidence interval is 0.000338. There are 0 homozygotes in GnomAdExome4. There are 222 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 25 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001540.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPB1
NM_001540.5
MANE Select
c.80G>Cp.Arg27Pro
missense
Exon 1 of 3NP_001531.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HSPB1
ENST00000248553.7
TSL:1 MANE Select
c.80G>Cp.Arg27Pro
missense
Exon 1 of 3ENSP00000248553.6
HSPB1
ENST00000447574.1
TSL:1
n.105G>C
non_coding_transcript_exon
Exon 1 of 2
HSPB1
ENST00000676231.2
c.80G>Cp.Arg27Pro
missense
Exon 1 of 4ENSP00000502249.1

Frequencies

GnomAD3 genomes
AF:
0.000164
AC:
25
AN:
152180
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000279
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000208
AC:
49
AN:
235340
AF XY:
0.000207
show subpopulations
Gnomad AFR exome
AF:
0.000292
Gnomad AMR exome
AF:
0.0000883
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000236
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000316
AC:
460
AN:
1456266
Hom.:
0
Cov.:
31
AF XY:
0.000306
AC XY:
222
AN XY:
724558
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33454
American (AMR)
AF:
0.0000449
AC:
2
AN:
44544
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26050
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39664
South Asian (SAS)
AF:
0.000372
AC:
32
AN:
86090
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49406
Middle Eastern (MID)
AF:
0.000181
AC:
1
AN:
5522
European-Non Finnish (NFE)
AF:
0.000368
AC:
409
AN:
1111400
Other (OTH)
AF:
0.000183
AC:
11
AN:
60136
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
28
57
85
114
142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000164
AC:
25
AN:
152298
Hom.:
0
Cov.:
33
AF XY:
0.000161
AC XY:
12
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41568
American (AMR)
AF:
0.0000653
AC:
1
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000279
AC:
19
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000185
Hom.:
0
Bravo
AF:
0.000212
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000251
AC:
1
ESP6500EA
AF:
0.000125
AC:
1
ExAC
AF:
0.000184
AC:
22
EpiCase
AF:
0.000382
EpiControl
AF:
0.000297

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3Benign:1
Mar 09, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Arg27Pro variant (rs367662394) variant was reported in one patient in a CMT cohort referred to for genetic testing (DiVincenzo 2014). This variant is listed in the Genome Aggregation Database (gnomAD) with a frequency of 0.06 percent in the South Asian population (identified on 17 out of 30,440 chromosomes). The arginine at position 27 is highly conserved up to fruitfly considering 12 species and computational analyses of the p.Arg27Pro variant on protein structure and function indicate a deleterious effect (SIFT: damaging, PolyPhen-2:possibly damaging). Altogether, there is not enough evidence to classify the p.Arg27Pro variant with certainty.

May 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 04, 2019
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 22, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The R27P variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. It was not observed with any significant frequency in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, nor with any significant frequency in the 1000 Genomes Project. The R27P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant

Charcot-Marie-Tooth disease Uncertain:1
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Sep 19, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: HSPB1 c.80G>C (p.Arg27Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00021 in 235340 control chromosomes, predominantly at a frequency of 0.00056 within the South Asian subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in HSPB1 causing Charcot-Marie Disease Axonal Type 2F, allowing no conclusion about variant significance. c.80G>C has been reported in the literature in individuals affected with Charcot-Marie Disease and congenital heart defects, without strong evidence for causality (Russell_2019, Volodarsky_2021). These report(s) do not provide unequivocal conclusions about association of the variant with Charcot-Marie Disease Axonal Type 2F. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 31453292, 32376792). ClinVar contains an entry for this variant (Variation ID: 245625). Based on the evidence outlined above, the variant was classified as uncertain significance.

HSPB1-related disorder Uncertain:1
Feb 08, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The HSPB1 c.80G>C variant is predicted to result in the amino acid substitution p.Arg27Pro. This variant was reported in an individual with congenital heart defect who also carries a missense variant in the CCR3 gene (Table 2, Russell et al 2019. PubMed ID: 31453292.) In addition, this variant was reported twice in a Canadian cohort study of Charcot-Marie-Tooth disease and was classified as uncertain (Supplementary table 2, Volodarsky M et al 2020. PubMed ID: 32376792). This variant is reported in 0.056% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

Inborn genetic diseases Benign:1
Jul 26, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Charcot-Marie-Tooth disease axonal type 2F Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.64
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.51
CADD
Pathogenic
33
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.86
D
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.87
D
MetaRNN
Pathogenic
0.91
D
MetaSVM
Pathogenic
0.92
D
MutationAssessor
Pathogenic
3.0
M
PhyloP100
9.1
PrimateAI
Pathogenic
0.86
D
PROVEAN
Uncertain
-3.8
D
REVEL
Pathogenic
0.92
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0050
D
Polyphen
0.97
D
Vest4
0.97
MVP
0.99
MPC
1.7
ClinPred
0.46
T
GERP RS
3.9
PromoterAI
0.034
Neutral
Varity_R
0.95
gMVP
0.98
Mutation Taster
=58/42
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs367662394; hg19: chr7-75932109; API